# OnCo record nct07168200 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07168200/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07168200", "NCT07168200" ;
  schema:name "A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the"@en ;
  schema:description "A phase 3 trial of Adebrelimab, Cisplatin, Carboplatin in cervical cancer, run by Shanghai Shengdi Pharmaceutical Co., Ltd, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07168200/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07168200> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-10-17" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/locally-advanced-cervical-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/adebrelimab/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:companies <https://onco.cc/companies/hengrui/> .